Skip to the page

Data / Drug companies / Toxicodendron pubescens leaf

Toxicodendron pubescens leaf: 6 companies and 17 products in the FDA NDC directory

Toxicodendron pubescens leaf is listed in the FDA National Drug Code Directory by 6 companies, with 17 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are pellet; liquid; tablet, and the newest product started marketing on March 27, 2024.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
6
Products
17
Generic (ANDA) products
0 (0.0%)
Application numbers
0
Routes
Oral, Sublingual
Brand names
Rhus Tox, WHP Poison Ivy, Rhus Toxicodendron, Oral Ivy Liquid, Rhus Toxicodendron, Hendel Rhus Tox
openFDA record search
api.fda.gov

Companies that list toxicodendron pubescens leaf

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Boiron12pelletUnapproved homeopathic productsMarch 3, 1983
MediNatura Inc1tabletUnapproved homeopathic productsJuly 12, 2016
Schwabe Mexico, S.A. de C.V.1liquidUnapproved homeopathic productsMarch 9, 2023
Schwabe North America, Inc.1liquidUnapproved homeopathic productsMarch 2, 2023
Sevene USA1pelletUnapproved homeopathic productsNovember 30, 2011
Washington Homeopathic Products1pelletUnapproved homeopathic productsMarch 27, 2024

Dosage forms

Dosage formProductsShare
Pellet1482.4%
Liquid211.8%
Tablet15.9%

Marketing categories

Marketing categoryProductsShare
Unapproved homeopathic products17100%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.